Malawi vs Tanzania, United Republic of: Protecting minority investors: Extent of corporate transparency index
Malawi
57.14
in 2019
Tanzania, United Republic of
57.14
in 2019
Malawi rank
82nd
Tanzania, United Republic of rank
82nd
Protecting minority investors: Extent of corporate transparency index over time
- Malawi
- Tanzania, United Republic of
How they compare
Malawi currently reports 57.14 against 57.14 in Tanzania, United Republic of, a difference of 0.
Across all 7 years both countries report, Tanzania, United Republic of has been ahead every year.
Malawi ranks 82nd and Tanzania, United Republic of ranks 82nd of 191 countries.
Frequently asked questions
- Which has higher protecting minority investors: extent of corporate transparency index, Malawi or Tanzania, United Republic of?
- Malawi, at 57.14 against 57.14 in Tanzania, United Republic of as of 2019.
- What is the difference in protecting minority investors: extent of corporate transparency index between Malawi and Tanzania, United Republic of?
- 0, with Malawi ahead.
- How many years of comparable data are there for Malawi and Tanzania, United Republic of?
- 7 years are reported by both, from 2013 to 2019.
- How do Malawi and Tanzania, United Republic of rank globally for protecting minority investors: extent of corporate transparency index?
- Malawi ranks 82nd and Tanzania, United Republic of ranks 82nd of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Extent of corporate transparency index (0-7) (DB15-20 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for extent of corporate transparency index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB15-20 studies.